Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis

Abstract Background Allergy immunotherapy (AIT), in the form of subcutaneous immunotherapy (SCIT) with alum-precipitated aqueous extracts, SCIT with a modified ragweed pollen allergen tyrosine adsorbate (MRPATA; Pollinex®-R), or a sublingual immunotherapy (SLIT)-tablet are options for the treatment...

Full description

Bibliographic Details
Main Authors: Anne K. Ellis, Douglas P. Mack, Rémi Gagnon, Eva Hammerby, Sheena Gosain
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Online Access:https://doi.org/10.1186/s13223-023-00758-7